Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation
Dhar et al used primary human and mouse natural killer (NK) cells to demonstrate that tumor-derived NKG2D ligand soluble MIC (sMIC) can reprogram the NK cells to secrete pro-tumorigenic cytokines with diminished cytotoxicity and polyfunctional potential. Their study provides a rationale for co-targe...
Guardado en:
Autores principales: | Payal Dhar, Fahmin Basher, Zhe Ji, Lei Huang, Si Qin, Derek A. Wainwright, Jerid Robinson, Shaye Hagler, Jing Zhou, Sean MacKay, Jennifer D. Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0aee9ce5734644cbbebb591f8c4256a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NKG2A is a NK cell exhaustion checkpoint for HCV persistence
por: Chao Zhang, et al.
Publicado: (2019) -
NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection
por: Yadong Wang, et al.
Publicado: (2017) -
POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE
por: E. A. Shulenina, et al.
Publicado: (2017) -
Synergized regulation of NK cell education by NKG2A and specific Ly49 family members
por: Xiaoqian Zhang, et al.
Publicado: (2019) -
Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.
por: Leticia Huergo-Zapico, et al.
Publicado: (2014)